SOST and neoplasm: These findings imply that sclerostin, which is secreted locally by tumor cells, has a protective role in the progression of prostate cancer through the Wnt-signaling pathway inhibition, and elevated serum sclerostin levels reflect the increased activity of osteoblasts and osteocytes at the osteoblastic lesions induced by prostate cancer.